How does DH's earnings trend in 2024 compare to peers?

Definitive Healthcare Corp.'s (DH) earnings trend in 2024 was under pressure compared to its peers, as evidenced by the significant decline in its diluted EPS. While peers like Morgan Stanley (MS) and Barclays (BCS) reported robust EPS figures of $7.95 and $0.44, respectively, DH faced a challenging year with a negative diluted EPS of -$3.54. This indicates that DH's financial performance was not only below its historical averages but also underperformed relative to industry peers during the same period.

|code|Ticker|Name|Date|Diluted EPS|market_code|
|---|---|---|---|---|---|
|MS|MS.N|Morgan Stanley|20240331|2.02|169|
|DH|DH.O|Definitive|20240331|-0.08|185|
|BOKF|BOKF.O|BOK Financial|20240331|1.29|185|
|JPM|JPM.N|Jpmorgan Chase|20240331|4.44|169|
|MS|MS.N|Morgan Stanley|20240630|1.82|169|
|DH|DH.O|Definitive|20240630|-1.81|185|
|BOKF|BOKF.O|BOK Financial|20240630|2.54|185|
|JPM|JPM.N|Jpmorgan Chase|20240630|6.12|169|
|MS|MS.N|Morgan Stanley|20240930|1.88|169|
|DH|DH.O|Definitive|20240930|-1.12|185|